Clarius Group LLC’s Neurogene NGNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-1,176
| Closed | -$15K | – | 530 |
|
|
2022
Q3 | $15K | Hold |
1,176
| – | – | ﹤0.01% | 492 |
|
|
2022
Q2 | $24K | Hold |
1,176
| – | – | ﹤0.01% | 467 |
|
|
2022
Q1 | $113K | Hold |
1,176
| – | – | 0.01% | 486 |
|
|
2021
Q4 | $113K | Sell |
1,176
-4
| -0.3% | -$384 | 0.01% | 486 |
|
|
2021
Q3 | $171K | Buy |
1,180
+4
| +0.3% | +$580 | 0.02% | 413 |
|
|
2021
Q2 | $217K | Hold |
1,176
| – | – | 0.02% | 379 |
|
|
2021
Q1 | $289K | Sell |
1,176
-146
| -11% | -$35.9K | 0.03% | 292 |
|
|
2020
Q4 | $373K | Buy |
1,322
+146
| +12% | +$41.2K | 0.04% | 219 |
|
|
2020
Q3 | $282K | Buy |
+1,176
| New | +$282K | 0.04% | 221 |
|